Archives
-
HyperScribe™ Poly (A) Tailing Kit: Assay Design
2026-09-30
The HyperScribe™ Poly (A) Tailing Kit can turn polyadenylation into a deliberate experimental variable rather than a final processing step. This guide connects E-PAP chemistry, RNA quality controls, and translational assay design to evidence from an in vivo mRNA study.
-
HA-LNP PTEN mRNA for Transdermal Melanoma Therapy
2026-09-30
A 2026 Journal of Controlled Release study developed hyaluronate-conjugated lipid nanoparticles containing PTEN mRNA for topical, transdermal melanoma immunotherapy. By integrating HA-DMG during nanoparticle self-assembly, the platform combines particle stabilization with CD44-directed skin and tumor targeting, producing antitumor and immune-activating effects in preclinical models.
-
EZ Cap EGFP mRNA 5-moUTP Workflows
2026-09-29
Use EZ Cap EGFP mRNA 5-moUTP as a reproducible reporter for delivery, translation, viability, and imaging experiments. Its Cap1 structure, 5-moU chemistry, and optimized poly(A) tail support practical comparisons between transfection systems while keeping assay interpretation focused on functional protein expression.
-
Vidarabine Monohydrate: Assay Workflows
2026-09-29
Build more reproducible antiviral assays with Vidarabine monohydrate, a DMSO-soluble nucleoside analog suited to viral DNA synthesis and cell-based mechanism studies. This guide connects practical formulation, dose-response design, orthogonal readouts, and troubleshooting for herpes simplex virus research without overstating translational evidence.
-
8-Chloroadenosine: From RNA Flux to NSCLC Insight
2026-09-28
A translational framework for using 8-Chloroadenosine as a nucleoside analog and RNA synthesis inhibitor to connect transcriptional regulation research with lncRNA, IL-6 mRNA stability, and NSCLC mechanism studies.
-
HyperScript cDNA for Neuropathic Pain Assays
2026-09-28
The HyperScript First-Strand cDNA Synthesis Kit can support expression studies of neuroinflammation and oxidative stress in neuropathic pain models. This article connects a cerium oxide nanomedicine study to practical RNA-to-qPCR decisions while clarifying what cDNA measurements can—and cannot—show.
-
L-Threonine Workflows for Metabolic and ALP Research
2026-09-27
Use L-Threonine as a controlled nutrient variable in cell culture optimization and metabolic profiling—not as an ALP probe. A metal-free carbon-dot study offers a complementary, sensitive ALP assay concept, with practical guidance here for separating nutrient effects from assay interference.
-
HyperScript First-Strand cDNA Synthesis Kit for qPCR
2026-09-26
Translate angiogenesis-related RNA measurements into a practical workflow for ischemic wound research with careful primer selection, input titration, and qPCR controls. The HyperScript™ First-Strand cDNA Synthesis Kit is a useful option when studies include low-abundance targets or structured RNA, but the reference findings are biological evidence—not a validation of this kit.
-
PTGER4–HDAC Signaling Controls SPINK4 in Rectal Epithelium
2026-09-25
Anbazhagan and colleagues show that PGE2–PTGER4 signaling in rectal epithelial organoids is associated with reduced phosphorylation of class IIa HDACs and increased SPINK4 expression. By combining stromal-cell co-culture, pharmacologic perturbation, and spatial and molecular assays, the study proposes a pathway linking mesenchymal signals to an epithelial response relevant to mucosal repair, while leaving important questions about in vivo function unresolved.
-
RP3-340N1.2 Stabilizes IL-6 mRNA in NSCLC
2026-09-25
The study identifies the lncRNA RP3-340N1.2 as a post-transcriptional regulator that supports IL-6 mRNA stability in non-small cell lung cancer. Knockdown reduced tumor-cell proliferation and migration and weakened tumor-associated macrophage effects, linking an RNA-binding protein interaction to tumor-promoting communication between cells.
-
GPC3-HSP70 mRNA Nanovaccine for HCC
2026-09-24
The study reports an SP94-targeted mRNA nanovaccine encoding repeated GPC3 CTL epitopes fused to HSP70, designed to connect tumor delivery with antigen presentation and T-cell activation. In preclinical experiments, vaccination increased antigen-specific immune responses, and combining it with anti-PD-L1 therapy strengthened antitumor activity; the findings are promising but do not establish clinical efficacy.
-
Murine RNase Inhibitor for RNA Workflows
2026-09-24
Protect RNA during cDNA synthesis, real-time RT-PCR, and in vitro transcription workflows—even when reducing conditions are low. Murine RNase Inhibitor targets pancreatic-type RNases and offers an oxidation-resistant option, but it does not inhibit every RNase or improve circularization by itself.
-
RP3-340N1.2 Stabilizes IL-6 in NSCLC
2026-09-23
The study links the lncRNA RP3-340N1.2 to non-small cell lung cancer progression by showing that its knockdown increases ZC3H12A association with IL-6 mRNA and accelerates IL-6 mRNA decay. Functional experiments further connect this RNA-regulatory mechanism with cancer-cell behavior and macrophage-associated signaling, while leaving important questions for validation in more physiological models.
-
Vidarabine Monohydrate: A Causal Assay Guide
2026-09-23
Vidarabine monohydrate is a nucleoside analog for dissecting viral DNA replication rather than simply ranking antiviral potency. This guide combines chemical handling, temporal assay design, and a carefully bounded lesson from modern molecular pharmacology to improve causal interpretation.
-
β-Pseudouridine: RNA Workflow & Applications
2026-09-22
β-Pseudouridine is a C-glycoside isomer of uridine for investigating RNA structure, translational fidelity, and stress-response biology. This guide separates free-nucleoside assay use from triphosphate-dependent RNA synthesis and translates recent self-amplifying RNA findings into practical experimental choices.